Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value
$3.52B
Total Bought
$0
Total Sold
$11.66M
Net Transaction
-$11.66M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ALIGNMENT HEALTHCARE(ALHC)60,993,32360,993,3230476,968720,94120.50%+243,973
CENTESSA PHARMACEUTICALS9,681,8189,681,818087,427154,8124.40%+67,385
SQUARESPACE10,611,07310,611,0730462,961492,67214.01%+29,711
AKERO THERAPEUTICS5,233,9895,233,9890122,789150,1634.27%+27,374
BLEND LABS(BLND)19,132,44019,132,440045,15371,7472.04%+26,594
XP, INC(XP)29,617,73329,617,7330520,976531,34215.11%+10,366
ROYALTY PHARMA(RPRX)1,500,0001,500,000039,55542,4351.21%+2,880
THIRD HARMONIC BIO2,958,7622,958,762038,46440,0911.14%+1,627
ACELYRIN2,889,6682,889,668012,74314,2460.41%+1,503
ALKAMI(ALKT)17,186,98515,520,318-1,666,667489,485489,51113.92%+25
WISH609,616609,61603,4813,3220.09%-158
ADAGENE264,000264,00008085860.02%-222
GROVE COLLABORATIVE(GROV)936,020936,02001,6571,2640.04%-393
PHARVARIS
COM
7,531,2527,531,2520141,588139,4793.97%-2,109
IMMUNOCORE(IMCR)1,261,6841,261,684042,75839,2761.12%-3,482
DLOCAL(DLO)63,906,69563,906,6950517,005511,25414.53%-5,752
RISKIFIED(RSKD)5,324,9985,324,998034,02725,1870.72%-8,839
OPENDOOR(OPEN)6,321,5190-6,321,51911,6320—-11,632
EUROPEAN WAX CENTER
CLASS A COM
13,110,49213,110,4920130,18789,1512.53%-41,036
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q3 2024 | TickerTrail